Archive

January 2026

Browsing

The House of Representatives has passed a federal funding package totaling nearly $180 billion, putting Congress one modest step closer to averting a government shutdown at the end of this month.

The legislation accounts for just over $174 billion aimed at partially or fully funding the departments of Commerce, Justice, Interior and Energy, including laying out the budget for NASA, the FBI and federal nuclear energy projects.

Republicans and Democrats overwhelmingly supported the final package of three bills, which passed by a 397-28 vote. Twenty-two Republicans and six Democrats voted against the bill.

It comes after the bills ran into opposition from conservative Republicans on Wednesday.

Members of the House Freedom Caucus and others on the GOP’s right flank were incensed in particular by the Commerce-Justice-Science (CJS) appropriations bill, which they felt rank-and-file lawmakers did not get proper input on putting together.

It’s one of 12 annual appropriations bills that Congress is tasked with passing each fiscal year. Congressional leaders who negotiated the legislation along bipartisan lines originally included it in a three-bill ‘minibus’ that, when passed in the House and Senate, would mean half of those dozen bills are finished.

Conservatives also threatened to kill the bill during a procedural vote on Wednesday afternoon over the inclusion of a community funding project requested by ‘Squad’ member Ilhan Omar, D-Minn.

The bill would have given $1,031,000 to Generation Hope’s Justice Empowerment Initiative, which ‘helps justice-involved Minneapolis residents break the cycle through job training and support,’ according to a description of the funding request.

But conservatives argued that the funding was just another vehicle allowing Minnesota’s Somali community to fraudulently take taxpayer funds at a time when the state is grappling with a massive fraud scandal enveloping its public service programs.

‘Fraud is running RAMPANT in Minnesota under the failed leadership of Tim Walz. Democrats want to use earmarks to funnel another $1 MILLION to a Somali-led so-called ‘Justice Empowerment Initiative’ that ABUSES taxpayer dollars,’ Rep. Ralph Norman, R-S.C., said on X.

Community project funding, also known as an ‘earmark,’ is a request that specific lawmakers make that allows their districts to directly benefit from Congress’ federal funding bills.

‘Earmarks, the currency of corruption, they’re coming back in full force in these products. And I just don’t support it,’ Rep. Chip Roy, R-Texas, told reporters Wednesday morning.

He was among the conservatives who Speaker Mike Johnson, R-La., negotiated with on the House floor for nearly half an hour as the minibus was in danger of failing during a procedural vote to allow for it to be debated.

In the end, House GOP leaders agreed to hold a separate vote on the CJS spending bill while also removing Omar’s earmark, which was also supported by Minnesota’s two Democrat senators.

‘Chalk one up for the good guys. Proud to work the last two days to stop the outrageous Ilhan Omar $1 million Somali earmark. Much more to do,’ Roy posted on X.

The CJS bill was first voted on, followed by the remaining two as a pair, and then a final vote on combining them before sending them to the Senate.

House Freedom Caucus Chairman Andy Harris, R-Md., told Fox News Digital he still anticipated ‘a number of’ his members will still vote against that bill specifically.

The legislation passed along bipartisan lines Thursday, with top House Appropriations Committee Democrat Rosa DeLauro, D-Conn., celebrating that the bill was free of GOP ‘poison pills’ earlier this week.

Its funding levels are above what was originally requested by President Donald Trump but below the threshold extending former President Joe Biden’s fiscal year 2024 spending levels via another continuing resolution would have brought.

The White House has also issued a statement of support for the minibus, which will be combined back into one bill before being sent to the Senate.

Congress has until the end of Jan. 30 to find a solution on the remaining six appropriations bills to avert another shutdown.

This post appeared first on FOX NEWS

European allies are working together on a plan in case the Trump administration acts on acquiring Greenland, a report said Wednesday. 

French Foreign Minister Jean-Noel Barrot told France Inter radio that the subject will be raised at a meeting with the foreign ministers of Germany and Poland. 

‘We want to take action, but we want to do so together with our European partners,’ Barrot said, according to Reuters.

A German government source also told Reuters that Germany is ‘closely working together with other European countries and Denmark on the next steps regarding Greenland.’

The White House said on Tuesday that President Donald Trump views acquiring Greenland as a national security priority and that the use of the U.S. military remains an option as his administration weighs how to pursue control of the Arctic territory.

‘President Trump has made it well known that acquiring Greenland is a national security priority of the United States,’ White House press secretary Karoline Leavitt said in a statement to Fox News.  

‘The President and his team are discussing a range of options to pursue this important foreign policy goal, and of course, utilizing the U.S. Military is always an option at the Commander in Chief’s disposal,’ she added. 

When asked Wednesday for a response to the Reuters report, the White House referred Fox News Digital to Leavitt’s remarks.

Trump told reporters on Air Force One over the weekend that the U.S. needs Greenland, a Danish territory, for ‘national security.’ 

European and Nordic leaders pushed back against the comments, with Finnish President Alexander Stubb, Norwegian Prime Minister Jonas Gahr Støre and Denmark’s Ambassador to the United States Jesper Møller Sørensen underscoring their support for Denmark’s sovereignty over Greenland and stressing that its future must be determined by Greenland and Denmark alone.

A senior European official told Reuters on Wednesday that Denmark must lead any effort to coordinate a response and ‘the Danes have yet to communicate to their European allies what kind of concrete support they wish to receive.’ 

Fox News Digital’s Jasmine Baehr and Ashley Carnahan contributed to this report. 

This post appeared first on FOX NEWS

The House of Representatives passed a bill to revive and extend COVID-19 pandemic-era enhanced Obamacare subsidies in a major victory for Minority Leader Hakeem Jeffries, D-N.Y.

Seventeen House Republicans broke ranks with GOP leaders to support the legislation after Democrats were successful in forcing a vote via a mechanism called a privileged resolution. The bill passed 230-196.

A discharge petition is a mechanism for getting legislation considered on the House floor even if the majority’s leadership is opposed to it, provided the petition gets a majority of House lawmakers’ signatures.

Jeffries filed a discharge petition late last year, which was then signed by four House Republicans — helping it clinch the critical majority threshold.

Five more House Republicans joined Democrats in a vote Wednesday evening to advance the legislation for final consideration Thursday.

The 17 Republicans who voted for the legislation were Reps. Brian Fitzpatrick, R-Pa.; Mike Lawler, R-N.Y.; Rob Bresnahan, R-Pa.; Ryan Mackenzie, R-Pa.; Mike Carey, R-Ohio; Monica De La Cruz, R-Texas; Andrew Garbarino, R-N.Y.; Will Hurd, R-Colo.; Dave Joyce, R-Ohio; Tom Kean Jr., R-N.J., Nick LaLota, R-N.Y., Max Miller, R-Ohio; Zach Nunn, R-Iowa; Maria Salazar, R-Fla.; Dave Valadao, R-Calif.; Derrick Van Orden, R-Wis.; and Rob Wittman, R-Va.

It underscores the perilously slim margins Speaker Mike Johnson, R-La., is governing with.

House Republicans hold just a two-vote majority with full attendance on both sides, numbers that could easily shift when lawmakers are absent for personal or health reasons.

As Rep. Tim Burchett, R-Tenn., put to reporters on Wednesday morning, ‘We are one flu season away from losing the majority.’

The successful vote on Thursday is a blow for Johnson, who argued for weeks that the majority of House Republicans were opposed to extending the COVID-19 pandemic-era tax subsidies.

But a significant number of GOP moderates were frustrated that their party leaders in the House and Senate had done little to avert a price hike for millions of Americans’ insurance premiums. 

A Democrat-controlled Congress voted twice, in 2020 and in 2021, to enhance Obamacare subsidies to give more people access to federal healthcare during the pandemic.

Those subsidies were only extended through 2025, however.

The vast majority of Republicans believe the subsidies are a COVID-era relic of a long-broken federal healthcare system. Conservatives argued that the relatively small percentage of Americans who rely on Obamacare meant that an extension would do little to ease rising health costs that people across the country are experiencing.

But a core group of moderates has been arguing that a failure to extend a reformed version of them would force millions of Americans to grapple with skyrocketing healthcare costs this year.

Those moderates were also frustrated with Jeffries for not working with Republicans on a bipartisan solution to the subsidies but felt they were left with little choice but to support Democrats’ bid in the end.

House Republicans passed a healthcare bill in mid-December aimed at lowering those costs for a broader swath of Americans, but that legislation has not been taken up in the Senate.

There’s also little chance the three-year extension will pass the upper chamber, however. Similar legislation led by Senate Democrats failed to reach the necessary 60-vote threshold to advance in December.

This post appeared first on FOX NEWS

President Donald Trump said on Thursday that he plans to meet with Venezuelan opposition leader Maria Corina Machado in Washington next week.

During an appearance on Fox News’ ‘Hannity,’ Trump was asked if he intends to meet with Machado after the U.S. struck Venezuela and captured its president, Nicolás Maduro.

‘Well, I understand she’s coming in next week sometime, and I look forward to saying hello to her,’ Trump said.

This will be Trump’s first meeting with Machado, who the U.S. president stated ‘doesn’t have the support within or the respect within the country’ to lead.

According to reports, Trump’s refusal to support Machado was linked to her accepting the 2025 Nobel Peace Prize, which Trump believed he deserved.

But Trump later told NBC News that while he believed Machado should not have won the award, her acceptance of the prize had ‘nothing to do with my decision’ about the prospect of her leading Venezuela.

This post appeared first on FOX NEWS

President Donald Trump announced in an early Friday morning Truth Social post that he has ‘cancelled the previously expected second Wave of Attacks’ against Venezuela in light of the ‘cooperation’ between the foreign nation and the U.S.

‘Venezuela is releasing large numbers of political prisoners as a sign of ‘Seeking Peace.’ This is a very important and smart gesture. The U.S.A. and Venezuela are working well together, especially as it pertains to rebuilding, in a much bigger, better, and more modern form, their oil and gas infrastructure. Because of this cooperation, I have cancelled the previously expected second Wave of Attacks, which looks like it will not be needed, however, all ships will stay in place for safety and security purposes,’ Trump said in the post.

He noted that he will meet with ‘BIG OIL’ figures at the White House on Friday.

‘At least 100 Billion Dollars will be invested by BIG OIL, all of whom I will be meeting with today at The White House. Thank you for your attention to this matter!’ he declared in the post.

The president’s comments come after he unilaterally ordered an attack against Venezuela last week in which U.S. forces successfully captured Nicolás Maduro.

Trump noted in a Wednesay Truth Social post, ‘I have just been informed that Venezuela is going to be purchasing ONLY American Made Products, with the money they receive from our new Oil Deal. These purchases will include, among other things, American Agricultural Products, and American Made Medicines, Medical Devices, and Equipment to improve Venezuela’s Electric Grid and Energy Facilities.’

‘In other words, Venezuela is committing to doing business with the United States of America as their principal partner – A wise choice, and a very good thing for the people of Venezuela, and the United States. Thank you for your attention to this matter!’ he added.

This post appeared first on FOX NEWS

Investor Insight

E-Power Resources offers investors high-grade exposure to the rapidly expanding flake graphite sector through one of Québec’s most promising districts. With a strategic land position, near-surface discoveries, and a leadership team experienced in exploration and capital markets, E-Power is positioned to help supply North America’s critical battery materials chain.

Overview

E-Power Resources (CSE:EPR) is a Montréal-based company focused on advancing its flagship Tetepisca graphite property in Québec’s North Shore region. The company’s mission is to delineate and develop a high-grade, near-surface flake-graphite resource capable of supplying future North American battery-anode demand.

Since entering the Tetepisca district in 2019, E-Power has systematically advanced its project from regional geophysics to mapping, sampling, drilling and metallurgical testing. This disciplined exploration pipeline has confirmed the presence of district-scale, high-purity graphite mineralization within the same geological sequence that hosts neighboring deposits such as Focus Graphite’s Lac Tetepisca and Nouveau Monde Graphite’s Uatnan, which together hold more than 120 million tons (Mt) measured + indicated at approximately 14 percent Cg.

Graphite demand is accelerating globally as electric-vehicle production and energy-storage capacity expand. Québec’s hydroelectric grid, pro-mining policy environment, and rapidly developing anode-manufacturing infrastructure make it a world-class jurisdiction for low-carbon graphite development. Within this setting, E-Power’s land position, grade profile and technical results uniquely position the company to become a core participant in Canada’s graphite-to-battery supply chain.

Company Highlights

  • Flagship project in Québec’s premier graphite district: 100-percent-owned Tetepisca Property, 234 contiguous claims covering ≈ 12,840 ha, the largest land position in the district
  • Exceptional grades: 2025 surface sampling returned up to 68.7 percent Cg (carbon in graphite form) at the Graphi-Centre target, among the highest reported globally
  • High-purity metallurgy: 2024 bulk sampling produced concentrates grading up to 96.4 percent Cg, validating commercial potential.
  • Strategic infrastructure advantage: ~220 km from Baie-Comeau and within trucking distance of a planned 200,000 tons per year (tpy) graphite-anode facility, anchoring Québec’s battery-materials hub.
  • Surging Market Demand: With global battery production accelerating, the graphite market is forecast to soar, positioning E-Power to benefit from one of the most dynamic growth trends in the energy materials sector.
  • Led by Experience: Backed by a strong, technically skilled management team, E-Power is strategically positioned to advance North American graphite independence and capture growing demand in the energy transition economy.

Key Project

Tetepisca Graphite Project

The Tetepisca graphite property is approximately 220 km north of Baie-Comeau, covering 234 contiguous claims (~12,840 ha) in the heart of the Tetepisca Graphite District (TGD). The property is 100-percent-owned by E-Power and hosts the same graphitic metasedimentary units that define the district’s producing and feasibility-stage assets.

District-Scale Opportunity

The TGD is an emerging flake-graphite camp that now hosts more than 120 Mt of measured and indicated resources averaging ~14 percent Cg across nearby projects such as Nouveau Monde Graphite’s Uatnan and Focus Graphite’s Lac Tetepisca deposits.

E-Power controls the largest contiguous land position in the district, strategically covering the same graphitic metasedimentary horizons that host these deposits. The district’s proximity to the planned 200,000 tpy graphite-anode facility in Baie-Comeau creates a unique alignment of resource, infrastructure and processing capability, positioning E-Power as a potential key upstream feed source for Québec’s integrated graphite-to-anode supply chain.

2024–2025 Exploration Results

E-Power’s work since 2021 has validated the property’s high-grade, near-surface potential.

  • The 2025 Phase 1 program returned grab samples up to 68.7 percent Cg at the Graphi-Centre target, one of the highest surface graphite grades reported globally.
  • New discoveries on the northern claim block (N3 and N4 targets) yielded multiple samples exceeding 20 percent Cg, extending graphite mineralization across more than 330 meters of strike within continuous conductive trends.
  • The Syndicate Trend, a 12 km linear conductor in the southwest, produced a new showing with grades of 54.7 percent Cg within a broader corridor that includes a historical drill intercept of 12.74 percent Cg over 9.55 meters.
  • Metallurgical test work from 2024 bulk sampling confirmed high-purity concentrates of up to 96.4 percent Cg, with additional mineralogy and flake-size distribution studies underway to define commercial product potential.

E-Power’s 2025–2026 work program will focus on advancing the Tetepisca property toward an initial resource estimate. Key activities include expanded fieldwork and metallurgical testing at the Graphi-Centre, Captain Cosmos and Syndicate showings; follow-up ground and drone-borne geophysical surveys to refine drill targets; and a focused drilling campaign designed to define near-surface, high-grade graphite zones. In parallel, the company is initiating early environmental baseline and access studies to support future development and potential partnerships within Québec’s growing graphite-to-anode supply chain.

Management Team

Jean-Michel Gauthier – Chief Executive Officer

Jean-Michel Gauthier contributes significant expertise in capital markets, corporate development and strategic positioning within the resource sector. His focus will be on ensuring the optimal deployment of capital and maximizing the inherent value of the Tetepisca Project as it advances through key de-risking stages.

Mark Billings – Chairman of the Board

Mark Billings is a highly respected finance professional in the Canadian resource sector, bringing extensive investment banking and corporate finance experience. His prior roles, including VP corporate finance at Desjardins Securities, provide a crucial foundation for guiding E-Power’s capital formation and strategic financing plans necessary for the Tetepisca Project’s development phases.

Jamie Lavigne – Chief Operating Officer

Jamie Lavigne is a professional economic geologist with over 30 years of experience in exploration and mine development. He has worked with major Canadian and Australian mining companies and several junior explorers and operates his own consulting firm. Lavigne holds a B.Sc. from Memorial University and an MSc. from the University of Ottawa. He is a member of L’Ordre des Géologues du Québec and the Northwest Territories and Nunavut Association of Professional Engineers and Geoscientists.

Paul Haber – Chief Financial Officer and Corporate Secretary

Paul Haber brings over 20 years of experience in corporate finance and capital markets. He has served as CFO, board member, and audit chair for numerous public and private companies, including XTM (CSE:PAID), South American Silver (TSX:SAC), and Migao Corporation (TSX:MGO). A CPA and CA, Haber began his career at Coopers & Lybrand and holds an Honours B.A. in Management from the University of Toronto. He also holds a Chartered Director designation from the DeGroote School of Business and the Conference Board of Canada.

Christian Falk – Advisory Board Member

Christian Falk is co-founder of Camet AG, Zug Switzerland and Vega Metals Trading in Montreal, Canada. He offers more than 16 years of global mining and metals trading experience, including significant tenure with Glencore International AG. His expertise in global graphite and critical metals markets will be critical in formulating E-Power’s downstream commercial strategy and understanding customer specifications.
This post appeared first on investingnews.com

Discoveries made by companies in the genetics sector help support every other life science industry in a variety of ways.

One of the genetic sector’s major contributions is the discovery of new genetic drivers of diseases. Genetic testing has grown substantially over the last few years, thanks to advances in technology; growth has also been spurred by an increase in chronic diseases and the continuing development of test kits for therapeutic areas with unmet medical needs.

Gene therapy is also a huge driver of growth in the overarching genetics market. This important segment of the life science market is focused on how genes can help treat or prevent serious conditions in patients. This includes the potential for healthcare professionals to implement gene therapy at the cellular level instead of using medication or surgery, replacing ‘faulty’ genes with new ones to potentially cure diseases.

Pharma and biotech companies often dabble in genetics along with their core disciplines, meaning that some firms may also have operations in other areas.

The top NASDAQ genetics stocks listed below have products related to gene therapy, genetic testing, genetically defined cancers and rare genetic diseases.

Data for this list of genetics stocks on the NASDAQ was collected on December 31, 2025, using TradingView’s stock screener, and stocks with market caps above US$50 million were considered.

1. Avidity Biosciences (NASDAQ:RNA)

Year-over-year gain: 143.8 percent
Market cap: US$10.87 billion
Share price: US$72.14

Avidity Bioscience is a biopharma firm developing a new form of RNA therapy called antibody oligonucleotide conjugates (AOC) that target the genes causing rare muscle diseases.

Through its proprietary AOC platform, Avidity developed programs for three rare muscle diseases: AOC 1001 for myotonic dystrophy type 1, AOC 1044 for Duchenne muscular dystrophy and AOC 1020 for facioscapulohumeral muscular dystrophy. The company is also working to expand its pipeline into cardiology and immunology.

In October 2025, Avidity entered into a definitive agreement to be acquired by Novartis (NYSE:NVS), which will include the company’s late-stage neuromuscular programs (AOC 1001, 1020, 1044) and the AOC platform, for US$12 billion.

Avidity’s early-stage precision cardiology programs will spin off into a new public company prior to closing in H1 2026. The spin-off will also have rights to use and develop the AOC platform for cardiology applications.

2. Wave Life Sciences (NASDAQ:WVE)

Year-over-year gain: 36.52 percent
Market cap: US$3.13 billion
Share price: US$17.12

Wave Life Sciences is another clinical-stage firm focused on unlocking insights from human genetics to deliver RNA-based medicines. The company’s PRISM platform is targeting both rare and prevalent disorders. Its pipeline includes clinical programs for Duchenne muscular dystrophy, alpha-1 antitrypsin deficiency and Huntington’s disease, as well as a preclinical program for WVE-007 in obesity.

Wave Life Sciences advanced its PRISM RNA platform across multiple programs in 2025. It is also performing a Phase 1 trial testing its WVE-007 obesity candidate, which is an investigational INHBE GalNAc-siRNA using Wave’s proprietary SpiNA design.

In December, the company reported positive interim data from the WVE-007 trial, which showed that a single dose resulted in sustained Activin E reduction, supporting infrequent dosing. Target engagement updates and body composition readouts are planned for Q1 2026.

3. UniQure (NASDAQ:QURE)

Year-over-year gain: 33.15 percent
Market cap: US$1.47 billion
Share price: US$23.86

UniQure is a gene therapy company focused on patients with severe medical needs. In November 2022, the US Food and Drug Administration (FDA) approved the company’s gene therapy Hemgenix (etranacogene dezaparvovec), which is the world’s first gene therapy for hemophilia B.

Today, uniQure’s proprietary gene therapy pipeline includes treatments for patients with Huntington’s disease, refractory temporal lobe epilepsy, ALS and Fabry disease.

Its gene therapy pipeline advanced in 2025, with positive Phase I/II topline data for Huntington’s disease candidate AMT-130 showing 75 percent slowing of disease progression at three years via cUHDRS, alongside 60 percent functional capacity preservation.

While data from the Phase I/II study led the FDA to grant AMT-130 breakthrough therapy designation in April, in December the agency told UniQure it believes the data may not be adequate to support a pre-biologics license application under the accelerated approval pathway. The company is pursuing a follow-up meeting.

4. Stoke Therapeutics (NASDAQ:STOK)

Year-over-year gain: 186.96 percent
Market cap: US$1.81 billion
Share price: US$31.74

Stoke Therapeutics is another biotech company with a focus on developing RNA medicine. With its proprietary research platform TANGO, which stands for targeted augmentation of nuclear gene output, the company is developing antisense oligonucleotides to selectively restore protein levels.

Stoke’s first product candidate, zorevunersen (STK-001), is in clinical testing for the treatment of Dravet syndrome, a severe form of genetic epilepsy. The company is also developing STK-002 for the treatment of autosomal dominant optic atrophy, an inherited optic nerve disorder.

Both candidates advanced in 2025, with STK-001 enrolling patients in Phase 3 after positive long-term data showed seizure reductions and cognitive gains. Likewise, STK-002’s clinical development program is being informed by results, presented in October, of a Phase 1 two year natural history study on the disease progression of autosomal dominant optic atrophy.

Securities Disclosure: I, Meagen Seatter, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

The copper price climbed to a fresh record on Tuesday (January 6), with persistent supply disruptions and trade uncertainty pushing the metal to a nearly 30 percent rally since October.

Benchmark three month copper on the London Metal Exchange (LME) rose as much as 3.1 percent in early trading to an all‑time high of US$13,387.50 per metric ton before settling slightly lower, but still above US$13,200.

The jump marks another milestone in a rally that first saw copper breach US$12,000 late in December last year.

Copper is widely used across the industrial economy, from construction and power infrastructure to electric vehicles and data centers that support artificial intelligence growth. Analysts attribute the gains to a combination of production setbacks at major mines and heightened concerns that prospective US trade tariffs could further disrupt flows.

Large copper-mining operations such as Freeport-McMoRan’s (NYSE:FCX) Grasberg complex in Indonesia have faced challenges since last year, while a strike at Capstone Copper’s (TSX:CS,ASX:CSC,OTC Pink:CSCCF) Mantoverde mine in Chile has reduced output prospects in one of the world’s top copper‑producing nations.

The threat of new tariffs under the Trump administration has also shaped expectations. Traders have moved to ship refined copper into the US ahead of any potential levies, tightening supply elsewhere. Furthermore, data show copper stocks in Comex warehouses have jumped to more than 450,000 metric tons, well above last year’s levels.

Copper outlook for 2026

Market watchers expect many of the forces that drove copper through 2025 to persist.

Supply constraints are expected to remain acute this year as aging mines and capacity shortfalls weigh on availability. New projects such as Arizona Sonoran Copper Company’s (TSX:ASCU,OTCQX:ASCUF) Cactus project and the long‑anticipated Resolution mine in the US are still years from significant output.

Copper demand is projected to grow as the global energy transition accelerates.

“A huge amount of this tightness has to do with US tariff concerns,” she said.

China, the world’s largest copper consumer, is also shaping the outlook. Despite weakness in its property sector, the country posted economic growth and is expected to prioritize copper‑intensive sectors under its new five year plan.

Longer‑term projections from industry groups suggest structural demand growth will outpace supply additions.

A UN report estimates that copper demand could rise 40 percent by 2040, requiring substantial investment and new mines just to keep pace. Likewise, Wood Mackenzie forecasts that copper demand will increase 24 percent by 2035, while the International Copper Study Group predicts a refined copper deficit of 150,000 metric tons in 2026 alone.

Securities Disclosure: I, Giann Liguid, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

Alain Corbani, head of mining at Montbleu Finance and manager of the Global Gold and Precious Fund, sees the gold price reaching US$5,000 per ounce in the near term.

He sees real interest rates and the US dollar as the key factors to watch, but noted that other elements are also adding tailwinds.

Securities Disclosure: I, Charlotte McLeod, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

Sen. Ted Cruz, R-Texas, on Wednesday called on Congress during a Senate hearing to impeach two federal judges, making his most elaborate case yet for imposing the extraordinary sanction on a pair of closely scrutinized jurists.

Cruz acknowledged that impeaching federal judges is exceedingly rare — 15 have been impeached in history, typically for straightforward crimes like bribery — but the Texas Republican argued it was warranted for judges James Boasberg and Deborah Boardman.

‘Rarer still, until now, were the deeper offenses the framers feared most — judges who, without necessarily breaking a criminal statute, violate the public trust, subvert the constitutional order or wield their office in ways that injure society itself,’ Cruz said. ‘That is why, throughout history, Congress recognized that impeachable misconduct need not be criminal.’

Cruz, a Senate Judiciary Committee member with an extensive legal background, said the House needed to initiate impeachment proceedings over controversial gag orders Boasberg signed in 2023 and a sentence Boardman handed down last year in the case of Justice Brett Kavanaugh’s attempted assassin.

Impeachment proceedings must be initiated in the House and typically run through the House Judiciary Committee.

Russell Dye, a spokesman for the GOP-led committee, said ‘everything is on the table’ when asked if Chairman Jim Jordan, R-Ohio, was open to the idea. If the House were to vote in favor of impeachment, it would then advance to the Senate. Two-thirds of senators would need to vote to convict the judges and remove them, a highly improbable scenario because the vote would require some support from Democrats.

Cruz’s counterpart at the hearing, Sen. Sheldon Whitehouse, D-R.I., defended the judges and accused Republicans of threatening impeachment as an effort to intimidate the judiciary because it routinely issues adverse rulings against the Trump administration.

‘There was a time when I’d have hoped a Senate Judiciary subcommittee would not be roped into a scheme to amplify pressure and threats against a sitting federal judge,’ Whitehouse said. ‘But here we are.’

In the case of Boardman, a Biden appointee, the judge sentenced Sophie Roske, who previously went by Nicholas Roske, to eight years in prison after the Department of Justice sought a 30-year sentence. Roske pleaded guilty to attempting to murder Kavanaugh. Boardman said she factored into her sentence that Roske identified as transgender and therefore faced unique adversity.

Cruz argued Democrats’ concerns about threats that judges have faced for ruling against President Donald Trump fell on deaf ears, in his view, because they did not speak out about Boardman’s leniency toward Roske.

‘My Democrat colleagues on this committee do not get to give great speeches about how opposed they are to violence against the judiciary, and, at the same time, cheer on a judge saying, ‘Well, if you attempt to murder a Supreme Court justice, and you happen to be transgender, not a problem. We’re going to deviate downward by more than two decades,” Cruz said.

In the case of Boasberg, former special counsel Jack Smith subpoenaed several Republican Congress members’ phone records while conducting an investigation into the 2020 election and Trump’s role in the Jan. 6 Capitol riot. Smith sought gag orders so that the senators would not immediately be notified about the subpoenas, and Boasberg authorized those orders.

Prosecutors seeking gag orders is not unusual, but senators have layers of protection from prosecution under the Constitution. The targeted Republicans have decried the subpoenas, saying their rights were violated.

Smith and an official representing the federal courts have both said that Boasberg was not notified that the subpoenas and gag orders were related to members of Congress.

Rob Luther, a law professor at George Mason University, was a witness for Republicans at the hearing and said Boasberg still should not have signed the gag orders without knowing who they applied to. Luther cited stipulations included in the orders.

‘One must ask on what basis Judge Boasberg found that the disclosure of subpoenas would result in destruction of or tampering with evidence, intimidation of potential witnesses, and cause serious jeopardy to the investigation, end quote,’ Luther said. ‘Did Judge Boasberg merely rubber stamp the requested gag order, or was he willfully blind?’

Smith’s actions also aligned with a DOJ policy at the time that did not require the special counsel to alert the court that the subpoenas targeted senators, a point raised by Sen. John Kennedy, R-La., during the hearing. Luther said the policy did not matter.

‘DOJ policy does not supplant federal law,’ he said.

This post appeared first on FOX NEWS